Live Quote · NASDAQBIIBHealthcare· Drug Manufacturers - General

Biogen Inc.

$249.59▲ 1.00%(+$2.46)
MKT CAP $36.89BNEXT EARNINGS Feb 5, 2027
50%
Bullish
TickerSpark Score
66/100
▌ Solid
64
Valuation
65
Profitability
25
Growth
76
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BIIB research report →

Analyst Price Target
$261.83+4.9% vs. today

Range $175 – $325

Analyst RatingBuy
33 Buy15 Hold1 Sell

Price Chart

+48.41% · this period
$254.87$209.64$164.42Nov 20May 26Nov 20
52-Week Range89% of range
Low
$160.36
Current
$249.59
High
$261.00

AI analysis · Last refreshed November 16, 2026 · Live quote · Not investment advice